[1]
2011. Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome. Dermatology Reports. 3, 3 (Dec. 2011), e55. DOI:https://doi.org/10.4081/dr.2011.e55.